Search Results - "Gasperi, V"

Refine Results
  1. 1

    GPR55 and its interaction with membrane lipids: comparison with other endocannabinoid-binding receptors by Gasperi, V, Dainese, E, Oddi, S, Sabatucci, A, Maccarrone, M

    Published in Current medicinal chemistry (2013)
    “…A number of integral membrane G protein-coupled receptors (GPCRs) share common structural features (including palmytoilated aminoacid residues and consensus…”
    Get more information
    Journal Article
  2. 2

    5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid by Massi, P, Valenti, M, Vaccani, A, Gasperi, V, Perletti, G, Marras, E, Fezza, F, Maccarrone, M, Parolaro, D

    Published in Journal of neurochemistry (01-02-2008)
    “…It has been recently reported that cannabidiol (CBD), a non-psychoactive cannabinoid, is able to kill glioma cells, both in vivo and in vitro, independently of…”
    Get full text
    Journal Article
  3. 3

    Endocannabinoids in adipocytes during differentiation and their role in glucose uptake by Gasperi, V, Fezza, F, Pasquariello, N, Bari, M, Oddi, S, Agrò, A Finazzi, Maccarrone, M

    “…The molecular basis for the control of energy balance by the endocannabinoid anandamide (AEA) is still unclear. Here, we show that murine 3T3-L1 fibroblasts…”
    Get full text
    Journal Article
  4. 4

    Alterations of the endocannabinoid system in an animal model of migraine: evaluation in cerebral areas of rat by Greco, R, Gasperi, V, Sandrini, G, Bagetta, G, Nappi, G, Maccarrone, M, Tassorelli, C

    Published in Cephalalgia (01-03-2010)
    “…Endocannabinoids are involved in the modulation of pain and hyperalgesia. In this study we investigated the role of the endocannabinoid system in the migraine…”
    Get more information
    Journal Article
  5. 5

    New insights into endocannabinoid degradation and its therapeutic potential by Bari, M, Battista, N, Fezza, F, Gasperi, V, Maccarrone, M

    Published in Mini reviews in medicinal chemistry (01-03-2006)
    “…Endocannabinoids are amides, esters and ethers of long chain polyunsaturated fatty acids, which act as new lipidic mediators. Anandamide…”
    Get more information
    Journal Article
  6. 6

    The first large population based twin study of coeliac disease by Greco, L, Romino, R, Coto, I, Di Cosmo, N, Percopo, S, Maglio, M, Paparo, F, Gasperi, V, Limongelli, M G, Cotichini, R, D'Agate, C, Tinto, N, Sacchetti, L, Tosi, R, Stazi, M A

    Published in Gut (01-05-2002)
    “…Background and aims: The genetic load in coeliac disease has hitherto been inferred from case series or anecdotally referred twin pairs. We have evaluated the…”
    Get full text
    Journal Article
  7. 7

    Human platelets express authentic CB₁ and CB₂ receptors by Catani, M V, Gasperi, V, Catanzaro, G, Baldassarri, S, Bertoni, A, Sinigaglia, F, Avigliano, L, Maccarrone, M

    Published in Current neurovascular research (01-11-2010)
    “…In the last decade, the neurovascular effects exerted by endocannabinoids (eCBs) have attracted growing interest, because they hold the promise to open new…”
    Get more information
    Journal Article
  8. 8

    Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol by Spoto, B., Fezza, F., Parlongo, G., Battista, N., Sgro', E., Gasperi, V., Zoccali, C., Maccarrone, M.

    Published in Biochimie (01-12-2006)
    “…Endocannabinoids are a group of biologically active endogenous lipids that have recently emerged as important mediators in energy balance control. The two best…”
    Get full text
    Journal Article
  9. 9

    Self-rated quality of life in celiac disease by CIACCI, C, D'AGATE, C, DE ROSA, A, FRANZESE, C, ERRICHIELLO, S, GASPERI, V, PARDI, A, QUAGLIATA, D, VISENTINI, S, GRECO, L

    Published in Digestive diseases and sciences (01-11-2003)
    “…As much as 1% of the gluten-consuming world is gluten-intolerant. New screening methods are increasingly identifying gluten intolerance in individuals…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Biological abnormalities of peripheral A2A receptors in a large representation of polyglutamine disorders and Huntington's disease stages by Varani, K, Bachoud-Lévi, A.-C, Mariotti, C, Tarditi, A, Abbracchio, M.P, Gasperi, V, Borea, P.A, Dolbeau, G, Gellera, C, Solari, A, Rosser, A, Naji, J, Handley, O, Maccarrone, M, Peschanski, Marc, DiDonato, S, Cattaneo, E

    Published in Neurobiology of disease (01-07-2007)
    “…Abstract Huntington’s disease is one of a group of hereditary neurodegenerative diseases characterized by a glutamine expansion (polyQ) in proteins which are…”
    Get full text
    Journal Article
  12. 12

    Cortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions by De March, Z, Zuccato, C, Giampà, C, Patassini, S, Bari, M, Gasperi, V, De Ceballos, M.L, Bernardi, G, Maccarrone, M, Cattaneo, E, Fusco, F.R

    Published in Neuroscience (27-03-2008)
    “…Abstract An involvement of one particular neurotrophin, namely, the brain-derived neurotrophic factor (BDNF), has been demonstrated in the pathophysiology…”
    Get full text
    Journal Article
  13. 13

    High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation by Turco, M.Y., Matsukawa, K., Czernik, M., Gasperi, V., Battista, N., Della Salda, L., Scapolo, P.A., Loi, P., Maccarrone, M., Ptak, G.

    Published in Human reproduction (Oxford) (01-10-2008)
    “…BACKGROUND The process of implantation is mediated by various molecules, one of which is anandamide (AEA), a lipid signalling ligand belonging to the family of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington's disease stages by Varani, K, Bachoud-Lévi, A-C, Mariotti, C, Tarditi, A, Abbracchio, M P, Gasperi, V, Borea, P A, Dolbeau, G, Gellera, C, Solari, A, Rosser, A, Naji, J, Handley, O, Maccarrone, M, Peschanski, Marc, DiDonato, S, Cattaneo, E

    Published in Neurobiology of disease (01-07-2007)
    “…Huntington's disease is one of a group of hereditary neurodegenerative diseases characterized by a glutamine expansion (polyQ) in proteins which are expressed…”
    Get full text
    Journal Article
  16. 16

    Appropriateness of urea breath test: a prospective observational study based on Maastricht 2000 guidelines by Perri, F., Ricciardi, R., Merla, A., Piepoli, A., Gasperi, V., Quitadamo, M., Andriulli, A.

    Published in Alimentary pharmacology & therapeutics (01-08-2002)
    “…Summary Background : The urea breath test is routinely used for diagnosing or confirming the eradication of Helicobacter pylori. Aim : To evaluate the…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons by Centonze, Diego, Rossi, Silvia, Prosperetti, Chiara, Gasperi, Valeria, De Chiara, Valentina, Bari, Monica, Tscherter, Anne, Febbraro, Fabia, Bernardi, Giorgio, Maccarrone, Mauro

    Published in Molecular and cellular neuroscience (01-06-2007)
    “…Synaptic transmission in the striatum is regulated by metabotropic glutamate (mGlu) receptors through pre- and postsynaptic mechanisms. We investigated the…”
    Get full text
    Journal Article
  19. 19
  20. 20